COMMUNIQUÉS West-GlobeNewswire

-
Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12/03/2025 - 21:30 -
The Cooperative of American Physicians Celebrates Its 50th Anniversary
12/03/2025 - 21:45 -
SCYNEXIS Reports Full Year 2024 Financial Results and Provides Corporate Update
12/03/2025 - 22:08 -
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12/03/2025 - 22:30 -
Kaerus Bioscience Successfully Completes Phase 1 Trial and Demonstrates Proof of Mechanism with its Novel BK Channel Modulator KER-0193 being developed for Fragile X Syndrome
11/03/2025 - 13:33 -
Coeptis Therapeutics Secures Worldwide Development and Commercialization Rights to Next-Generation GEAR™ Cell Therapy Platform Strengthening its High-Impact Precision Immuno-Oncology Pipeline
11/03/2025 - 13:34 -
GRI Bio Regains Compliance with Nasdaq’s Minimum Bid Price Rule
11/03/2025 - 13:35 -
AIM ImmunoTech Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
11/03/2025 - 13:45 -
Little Leaves Behavioral Services Expands in Maryland and Virginia
11/03/2025 - 13:51 -
AMPS Launches ClaimInsight: A Next-Generation Payment Integrity Suite Built for Accuracy, Speed, and Value
11/03/2025 - 14:00 -
NeuroOne® Accelerates Timeline of 510(k) Submission to FDA for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain
11/03/2025 - 14:00 -
Resmed Unveils Unified Brand to Lead the Global Sleep and Health Technology Revolution
11/03/2025 - 14:00 -
Woodstock Sterile Solutions Invests $8 million in New Automated, High-Speed, State-of-the-Art, Bottle Packaging Line
11/03/2025 - 14:00 -
Capricor Therapeutics to Present Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Update on March 19
11/03/2025 - 14:00 -
Progyny Expands Family Building Solutions with New Parent and Child Well-being Offering
11/03/2025 - 14:03 -
Medera Completes Patient Dosing in Phase 1/2a MUSIC-HFrEF Trial of SRD-001 Gene Therapy for Heart Failure with Reduced Ejection Fraction
11/03/2025 - 14:09 -
HealthEquity Community Foundation Announces First Grant Recipients and Opens Next Funding Cycle
11/03/2025 - 14:15 -
Better Choice Company Signs Binding Letter of Intent to Acquire Choice Specialty Pharmacy, Expanding U.S. Presence
11/03/2025 - 14:15 -
Baylor Genetics to Showcase Genetic Testing Innovations for Rare Disease at ACMG 2025 Annual Clinical Genetics Meeting
11/03/2025 - 15:00
Pages